A twice daily tablet for MS sufferers has been licensed in Britain. The drug is called Tecfidera and is already used by 35,000 patients around the world. This drug has been shown to reduce the rate of MS relapses by over 20% in adults with the most common form of the disease - relapsing remitting MS (oh well that's me screwed lol).
The drug is a modified version of a treatment that was originally used to treat the skin disease psoriasis. It's a new approach to treating MS which is believed to help cells defend themselves against the damage caused by MS.
No comments:
Post a Comment